Epigenomic profile of GBA1 in Parkinson's disease
Eloïse Berson(Stanford Medicine), Thomas J. Montine(Stanford University), Geidy E. Serrano(Banner Sun Health Research Institute), Amalia Perna(Stanford University), Nima Aghaeepour(Stanford Medicine), C. Dirk Keene(University of Washington), Matteo Santoro(University of Aberdeen), Kathleen S. Montine(Stanford University), Tomin James(Stanford University), David Seong(Stanford Medicine), Howard Y. Chang(Stanford University), Brenna Cholerton(Stanford University), Thomas G. Beach, Chi-Hung Shu(Stanford University), Syed Bukhari(Johns Hopkins University), Raphael Zaghroun(Stanford University), M. Ryan Corces(Gladstone Institutes)
Cited by 1
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
|Nature Methods|2017|2.8k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k